Urology · Baltimore, MD
NPI
1578584959
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3333 N Calvert St, Ste 600
Baltimore, MD, 21218
Phone (410) 467-7665
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.3M
13,691 services
Medicare patients, 2024
574
Average age 75
Drug cost, 2024
$15.6M
2,396 prescriptions
Company payments, 2025
$82K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Benjamin H Lowentritt was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 685 times for 453 patients. In total Benjamin H Lowentritt billed 13,691 services in 58 codes, and Medicare paid $2.3M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-04-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 685 | 453 | $12.04 | $8,246 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 647 | 88 | $49.58 | $32K |
| 99213 Office E&M - Established | Office | 509 | 363 | $63.77 | $32K |
| 36415 Venipuncture Blood Collection | Office | 429 | 308 | $8.61 | $3,694 |
| 81003 Clinical Chemistry | Office | 367 | 290 | $2.17 | $797 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 198 | 56 | $39.76 | $7,873 |
| 99214 Office E&M - Established | Office | 156 | 123 | $97.91 | $15K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 141 | 19 | $137.47 | $19K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 86 | 19 | $45.38 | $3,903 |
| 96402 Chemotherapy Administration | Office | 65 | 26 | $24.52 | $1,594 |
| 96413 Chemotherapy Administration | Office | 60 | 21 | $106.08 | $6,365 |
| 76872 Ultrasound - Nonspecific | Facility | 52 | 52 | $23.07 | $1,199 |
| 55700 Other Organ Systems | Facility | 51 | 51 | $90.83 | $4,632 |
| 52000 Cystourethroscopy | Facility | 44 | 37 | $58.67 | $2,582 |
| Q2043 Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion | Office | 42 | 17 | $42,994.89 | $1.8M |
By year: 2022 $2.4M for 10,481 services; 2023 $2.3M for 9,561 services; 2024 $2.3M for 13,691 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 429 | 308 | $8.61 | $3,694 |
| 81003 Clinical Chemistry | 367 | 290 | $2.17 | $797 |
Medicare prescription drug claims, 2024
In 2024, the drug Benjamin H Lowentritt prescribed most often to Medicare patients was Erleada (Apalutamide), with 427 prescriptions and refills. In total Benjamin H Lowentritt wrote 2,396 Medicare prescriptions that cost $15.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Erleada Apalutamide | 427 | 459 | 71 | $6.6M |
| Xtandi Enzalutamide | 379 | 397 | 70 | $5.5M |
| Abiraterone Acetate Generic | 359 | 369 | 69 | $978K |
| Prednisone Generic | 339 | 371 | 72 | $1,217 |
| Orgovyx Relugolix | 282 | 284 | 54 | $738K |
| Tamsulosin Hcl Generic | 190 | 424 | 55 | $3,312 |
| Nubeqa Darolutamide | 132 | 134 | 23 | $1.8M |
| Alfuzosin Hcl Er Alfuzosin Hcl | 44 | 102 | Under 11 | $1,610 |
| Myrbetriq Mirabegron | 40 | 72 | Under 11 | $32K |
| Levofloxacin Generic | 33 | 33 | 32 | $72.66 |
| Tadalafil Generic | 24 | 46 | Under 11 | $6,671 |
| Testosterone Generic | 23 | 33 | Under 11 | $1,935 |
| Finasteride Generic | 20 | 60 | Under 11 | $359 |
| Silodosin Generic | 12 | 26 | Under 11 | $887 |
| Sildenafil Citrate Generic | 11 | 19 | Under 11 | $168 |
Brand drugs: 1,263 claims; generic drugs: 1,133 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Benjamin H Lowentritt $82K ($82K in general payments such as food, travel and fees and $238 for research) from 27 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $32K.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 24 | $32K |
| Janssen Biotech, Inc. JNJ | 30 | $24K |
| Novartis Pharmaceuticals Corporation NVS | 8 | $7,818 |
| Pfizer Inc. PFE | 9 | $7,244 |
| Astellas Pharma US Inc 4503.T | 6 | $6,715 |
| Janssen Scientific Affairs, LLC JNJ | 4 | $1,308 |
| Dendreon Pharmaceuticals LLC | 21 | $1,041 |
| Histosonics, Inc. | 1 | $255 |
| Immunitybio, Inc. IBRX | 5 | $217 |
| Sumitomo Pharma America, Inc. 4506.T | 11 | $209 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.